cyclosporine has been researched along with Adenovirus Infections, Human in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Ajili, F; Bouguerra, C; Gouider, D; Khairallah, M; Khallouli, A; Ksiaa, I; Maalej, A; Yousfi, MA | 1 |
| Altınörs, DD; Asena, L; Burcu, A; Çolak, M; Ercan, E; Şıngar Özdemir, E | 1 |
| Bahar, I; Levinger, E; Sansanayudh, W; Slomovic, A; Slomovic, AR | 1 |
| Holsclaw, DS; Jeng, BH | 1 |
| Gesser, C; Kaulfers, PM; Loderstädt, U; Meyer-Rüsenberg, B; Richard, G | 1 |
| Comez, A; Coskun, E; Erbagci, I; Gurler, B; Kaydu, E; Okumus, S; Tatar, MG; Yayuspayi, R | 1 |
| Gordon, YJ; Pless, P; Romanowski, EG; Yates, KA | 1 |
| Birnbaum, F; Böhringer, D; Reinhard, T | 1 |
| Reinhard, T; Sundmacher, R | 1 |
| Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R | 2 |
| Hillenkamp, J; Reinhard, T; Sundmacher, R | 1 |
| Burtomboy, G; Cames, B; de Ville de Goyet, J; Lamy, M; Otte, JB; Rahier, J; Reding, R; Sokal, EM | 1 |
2 review(s) available for cyclosporine and Adenovirus Infections, Human
| Article | Year |
|---|---|
Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment.
Topics: Adenovirus Infections, Human; Chronic Disease; Cross-Sectional Studies; Cyclosporine; Disease Notification; Disinfection; Epidemics; Germany; Hand Disinfection; Humans; Immunosuppressive Agents; Incidence; Keratoconjunctivitis; Ophthalmic Solutions; Randomized Controlled Trials as Topic | 2011 |
[Prospects for therapy and prevention of adenovirus keratoconjunctivitis].
Topics: Adenovirus Infections, Human; Adolescent; Adrenal Cortex Hormones; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cyclosporine; Cytosine; Humans; Immunosuppressive Agents; Interferons; Keratitis; Keratoconjunctivitis, Infectious; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Recurrence; Time Factors | 2001 |
4 trial(s) available for cyclosporine and Adenovirus Infections, Human
| Article | Year |
|---|---|
Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study.
Topics: Adenovirus Infections, Human; Administration, Ophthalmic; Adolescent; Adult; Aged; Child; Conjunctivitis, Viral; Cyclosporine; Double-Blind Method; Epithelium, Corneal; Female; Fluorometholone; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Treatment Outcome; Visual Acuity | 2021 |
Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.
Topics: Adenovirus Infections, Human; Adult; Cyclosporine; Dose-Response Relationship, Drug; Epidemics; Epithelium, Corneal; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Ophthalmic Solutions; Prognosis; Retrospective Studies; Turkey | 2012 |
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Treatment Outcome | 2001 |
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Conjunctiva; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Eyelids; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Safety | 2002 |
7 other study(ies) available for cyclosporine and Adenovirus Infections, Human
| Article | Year |
|---|---|
Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.
Topics: Acute Disease; Adenovirus Infections, Human; Cyclosporine; Eye Infections, Viral; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Lubricant Eye Drops; Male; Ophthalmic Solutions; Prednisolone; Retrospective Studies; Treatment Outcome; Visual Acuity | 2017 |
Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
Topics: Adenovirus Infections, Human; Administration, Topical; Cyclosporine; Epithelium, Corneal; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Intraocular Pressure; Keratoconjunctivitis; Male; Middle Aged; Prognosis; Retrospective Studies; Surveys and Questionnaires; Visual Acuity | 2010 |
Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
Topics: Adenoviridae; Adenovirus Infections, Human; Adult; Aged; Aged, 80 and over; Child; Cyclosporine; Epithelium, Corneal; Eye Infections, Viral; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Visual Acuity | 2011 |
Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Chemotaxis, Leukocyte; Cyclosporine; Disease Models, Animal; Epithelium, Corneal; Female; Immunosuppressive Agents; Keratoconjunctivitis, Infectious; Ophthalmic Solutions; Rabbits; T-Lymphocytes; Virus Replication; Virus Shedding | 2005 |
[Cyclosporin A eyedrops for keratitis nummularis after adenovirus keratoconjunctivitis].
Topics: Adenovirus Infections, Human; Chronic Disease; Corneal Opacity; Cyclosporine; Humans; Immunosuppressive Agents; Keratitis; Keratoconjunctivitis; Ophthalmic Solutions | 2008 |
[Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis--case report].
Topics: Adenovirus Infections, Human; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Middle Aged; Ophthalmic Solutions; Recurrence; Treatment Outcome; Visual Acuity | 1997 |
Acute adenovirus hepatitis in liver transplant recipients.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Azathioprine; Biliary Atresia; Child, Preschool; Cyclosporine; Hepatitis, Viral, Human; Humans; Infant; Liver Diseases; Liver Transplantation; Necrosis; Prednisone; Time Factors | 1992 |